Elanco Animal Health Inc. ELAN Sales & Marketing

Sales & Marketing at other companies

Idexx LaboratoriesIDXX

$175.25M+12.2%

General MillsGIS

$211.88M+2.8%

Reportable Segment$256M+13.8%

Revenue$1.4B+14.9%

Gross profit$785.0M+14.8%

Net income$57.0M-14.9%

EPS (diluted)$0.11-15.4%

Cash & equivalents$428.0M-12.1%

Total debt$4.3B-1.7%

Total equity$6.5B+2.3%

Total assets$13.2B+2.2%

Operating cash flow$13.0M+425%

CapEx$51.0M-21.5%

Free cash flow-$38.0M+44.9%

Market cap$12.1B+128%

Enterprise value$15.99B+73.1%

P/S2.5×+1.3×

Gross margin55.1%+0.2pp

Net margin-4.9%-13.6pp

FCF margin6.4%-1.4pp

Return on equity-3.8%-9.9pp

Debt / equity0.7×0.0×

Current ratio2.2×-0.6×